ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,582.35
0.32%
Dow Jones
40,450.97
0.09%
US Dollar vs MXN
18.0822
0.76%
Brent Oil
80.095
-1.74%
Bitcoin
66,938.41
-0.99%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Provention Bio Inc (PRVB)

  7. Provention Bio Inc (PRVB) Noticias

PRVB

Provention Bio (PRVB)

Provention Bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRVB
FechaHoraFuenteTítuloSímboloCompañía
08/05/202315:18Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PRVBProvention Bio Inc
01/05/202305:20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVBProvention Bio Inc
28/04/202315:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVBProvention Bio Inc
27/04/202317:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVBProvention Bio Inc
27/04/202316:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVBProvention Bio Inc
27/04/202315:49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRVBProvention Bio Inc
27/04/202308:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVBProvention Bio Inc
27/04/202307:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PRVBProvention Bio Inc
19/04/202316:11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVBProvention Bio Inc
29/03/202316:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRVBProvention Bio Inc
24/03/202306:53Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVBProvention Bio Inc
24/03/202306:11Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PRVBProvention Bio Inc
24/03/202305:05Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PRVBProvention Bio Inc
17/03/202315:17Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRVBProvention Bio Inc
13/03/202315:39Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRVBProvention Bio Inc
13/03/202306:00PR Newswire (US)Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference CallNASDAQ:PRVBProvention Bio Inc
03/03/202315:05PR Newswire (US)Provention Bio Announces the Grant of Inducement AwardsNASDAQ:PRVBProvention Bio Inc
23/02/202307:30PR Newswire (US)Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023NASDAQ:PRVBProvention Bio Inc
13/02/202306:30PR Newswire (US)Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi USNASDAQ:PRVBProvention Bio Inc
08/02/202306:30PR Newswire (US)Provention Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:PRVBProvention Bio Inc
02/02/202315:01PR Newswire (US)Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®NASDAQ:PRVBProvention Bio Inc
05/01/202315:01PR Newswire (US)Provention Bio Announces Appointment of Rita Jain, M.D., to Board of DirectorsNASDAQ:PRVBProvention Bio Inc
21/11/202206:35TipRanksProvention Bio (PRVB) Receives a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
20/11/202222:15TipRanksSVB Securities Remains a Buy on Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202216:55TipRanksChardan Capital Sticks to Their Buy Rating for Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202204:09TipRanksProvention Bio (NASDAQ:PRVB) Stock Spikes as Diabetes Drug Gets FDA’s NodNASDAQ:PRVBProvention Bio Inc
17/11/202217:57Dow Jones NewsProvention Bio Up 8% on Diabetes Drug ApprovalNASDAQ:PRVBProvention Bio Inc
17/11/202217:39Dow Jones NewsProvention Bio Gets FDA OK for Diabetes DrugNASDAQ:PRVBProvention Bio Inc
17/11/202216:45PR Newswire (US)TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1DNASDAQ:PRVBProvention Bio Inc
06/11/202221:35TipRanksProvention Bio (PRVB) Gets a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PRVB

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NYSE
VZ
Verizon Communications
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
NASDAQ
AAPL
Apple
FX
EURMXN
Euro vs MXN
CCOM
US500
US 500
PM
XAUUSD
Gold vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
CCOM
OILBRENT
Brent Oil
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLF
Financial Select Sector
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados